OMS, in addition to neuroblastoma, can be linked to breast and ovarian cancer, as well as SCLC, and can be associated with various “high-risk” autoantibodies (Ri/ANNA-2, Hu/ANNA-1, Ma2, Yo/PCA1, etc.)[42]. The gene discussed is CDR2; the disease is ovarian cancer.